• Policy
• Advance reservations for SKYCovione will begin on the 1st
• by Kim, Jung-Ju Sep 2, 2022 06:02am

• Policy
• MFDS sets next year's budget at ₩669.4 billion
• by Lee, Hye-Kyung Sep 1, 2022 05:56am

• Policy
• Coverage of 19 new drug items will be reinforced this year
• by Kim, Jung-Ju Aug 31, 2022 05:40am

• Policy
• Reevaluation of Amosartan plus & Twotops Plus
• by Lee, Tak-Sun Aug 30, 2022 05:55am

• Policy
• Lorviqua reimb at ₩52,819, Emgality at ₩295,250
• by Kim, Jung-Ju Aug 30, 2022 05:55am

• Policy
• Zemimet’s price drops 9.7% in 5 years…discounted 5 times
• by Lee, Tak-Sun Aug 30, 2022 05:54am

• Policy
• Kyowa Hakogirtin Postelligeo 20mg is expected to be approved
• by Lee, Hye-Kyung Aug 30, 2022 05:54am

• Policy
• "Raise the prescription rate for high-risk patients to 50%"
• by Lee, Jeong-Hwan Aug 29, 2022 06:03am

• Policy
• NHI turns to deficit with a mere 2.6% coverage improvement
• by Lee, Jeong-Hwan Aug 26, 2022 05:35am

• Policy
• Pts with osteopenia need screening tx
• by Kim, Jung-Ju Aug 26, 2022 05:35am